OraSure Technologies, Inc. (OSUR)
- Previous Close
5.48 - Open
5.54 - Bid 5.46 x 400
- Ask 5.49 x 300
- Day's Range
5.44 - 5.57 - 52 Week Range
4.38 - 8.45 - Volume
654,478 - Avg. Volume
914,783 - Market Cap (intraday)
420.04M - Beta (5Y Monthly) 0.18
- PE Ratio (TTM)
7.62 - EPS (TTM)
0.72 - Earnings Date May 8, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
7.69
OraSure Technologies, Inc., together with its subsidiaries, provides point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services in the United States, Europe, and internationally. The company's products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D. saliva alcohol test. It also offers genomic products under the Oragene and ORAcollect brands for collecting genetic material from human saliva; Colli-Pee collection devices for the volumetric collection of void urine samples; and microbiome laboratory testing and analytical services. In addition, the company provides microbiome products, such as OMNIgene GUT for self-collecting microbial DNA from feces or stool samples for gut microbiome profiling; OMNIgene GUT DNA and RNA collection devices; and OMNIgene GUT Dx collection device for collection of human fecal samples and the stabilization of DNA from the bacterial community. Additionally, it provides other diagnostic products, such as immunoassays and other in vitro diagnostic tests. The company markets its products to clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, commercial and industrial entities, disease risk management, diagnostics, pharmaceutical, biotech, nutrition, companion animal, and environmental markets. OraSure Technologies, Inc. was incorporated in 2000 and is based in Bethlehem, Pennsylvania.
www.orasure.comRecent News: OSUR
Performance Overview: OSUR
Trailing total returns as of 5/3/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: OSUR
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: OSUR
Valuation Measures
Market Cap
420.04M
Enterprise Value
143.14M
Trailing P/E
7.62
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.01
Price/Book (mrq)
0.98
Enterprise Value/Revenue
0.35
Enterprise Value/EBITDA
2.22
Financial Highlights
Profitability and Income Statement
Profit Margin
13.23%
Return on Assets (ttm)
7.29%
Return on Equity (ttm)
13.50%
Revenue (ttm)
405.47M
Net Income Avi to Common (ttm)
53.66M
Diluted EPS (ttm)
0.72
Balance Sheet and Cash Flow
Total Cash (mrq)
290.41M
Total Debt/Equity (mrq)
3.14%
Levered Free Cash Flow (ttm)
137.35M
Research Analysis: OSUR
Company Insights: OSUR
OSUR does not have Company Insights